InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
4
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Windsor James Brian, See Remarks. Director active across 3 companies, notably Rein Therapeutics, Inc.. Cumulatively, 5 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €32k. History available since 20 November 2023. The latest transaction was filed on 30 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Windsor James Brian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
25,000 股@ US$1.000.067% mcap50.0% 占其流量Common stock , $0.001 par valueSEC:0001193125-26-220718:0
标准退出：2026年7月29日 (T+90)
239 股@ US$2.24100.0% 占其流量Common StockSEC:0000950170-24-134522:0
标准退出：2025年3月5日 (T+90)
2,000 股Common StockSEC:0000950170-24-027304:0
225 股@ US$3.377.0% 占其流量Common StockSEC:0000950170-23-071200:0
标准退出：2024年3月14日 (T+90)
5,076 股@ US$1.967593.0% 占其流量Common StockSEC:0000950170-23-065545:0
标准退出：2024年2月18日 (T+90)
5 条申报中的 5 条
About Windsor James Brian
James Brian Windsor is associated with Rein Therapeutics, Inc. His role is noted as 'see remarks', indicating involvement in specific activities within the company. Details of his responsibilities are not provided.
